|
Phenotypic Information (metabolism pathway, cancer, disease, phenome) | |
Gene-Gene Network Information: Co-Expression Network, Interacting Genes & KEGG | |
Gene Summary for GALNT14 |
Basic gene info. | Gene symbol | GALNT14 |
Gene name | polypeptide N-acetylgalactosaminyltransferase 14 | |
Synonyms | GALNT15|GalNac-T10|GalNac-T14 | |
Cytomap | UCSC genome browser: 2p23.1 | |
Genomic location | chr2 :31133330-31361592 | |
Type of gene | protein-coding | |
RefGenes | NM_001253826.1, NM_001253827.1,NM_024572.3,NR_045602.1, | |
Ensembl id | ENSG00000158089 | |
Description | UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 14UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase T10UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase T14UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltran | |
Modification date | 20141207 | |
dbXrefs | MIM : 608225 | |
HGNC : HGNC | ||
Ensembl : ENSG00000158089 | ||
HPRD : 12194 | ||
Vega : OTTHUMG00000074077 | ||
Protein | UniProt: go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_GALNT14 | |
BioGPS: 79623 | ||
Gene Expression Atlas: ENSG00000158089 | ||
The Human Protein Atlas: ENSG00000158089 | ||
Pathway | NCI Pathway Interaction Database: GALNT14 | |
KEGG: GALNT14 | ||
REACTOME: GALNT14 | ||
ConsensusPathDB | ||
Pathway Commons: GALNT14 | ||
Metabolism | MetaCyc: GALNT14 | |
HUMANCyc: GALNT14 | ||
Regulation | Ensembl's Regulation: ENSG00000158089 | |
miRBase: chr2 :31,133,330-31,361,592 | ||
TargetScan: NM_001253826 | ||
cisRED: ENSG00000158089 | ||
Context | iHOP: GALNT14 | |
cancer metabolism search in PubMed: GALNT14 | ||
UCL Cancer Institute: GALNT14 | ||
Assigned class in ccmGDB | C |
Top |
Phenotypic Information for GALNT14(metabolism pathway, cancer, disease, phenome) |
Cancer Description | |
Cancer | CGAP: GALNT14 |
Familial Cancer Database: GALNT14 |
* This gene is included in those cancer gene databases. |
. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Oncogene 1 | Significant driver gene in |
cf) number; DB name 1 Oncogene; http://nar.oxfordjournals.org/content/35/suppl_1/D721.long, 2 Tumor Suppressor gene; https://bioinfo.uth.edu/TSGene/, 3 Cancer Gene Census; http://www.nature.com/nrc/journal/v4/n3/abs/nrc1299.html, 4 CancerGenes; http://nar.oxfordjournals.org/content/35/suppl_1/D721.long, 5 Network of Cancer Gene; http://ncg.kcl.ac.uk/index.php, 1Therapeutic Vulnerabilities in Cancer; http://cbio.mskcc.org/cancergenomics/statius/ |
Metabolic Pathway Description | |
REACTOME_METABOLISM_OF_PROTEINS |
Mutations for GALNT14 |
* Under tables are showing count per each tissue to give us broad intuition about tissue specific mutation patterns.You can go to the detailed page for each mutation database's web site. |
Structural Variants in COSMIC: go to COSMIC mutation histogram |
- Statistics for Tissue and Mutation type | Top |
- For Inter-chromosomal Variations |
There's no inter-chromosomal structural variation. |
- For Intra-chromosomal Variations |
* Intra-chromosomal variantions includes 'intrachromosomal amplicon to amplicon', 'intrachromosomal amplicon to non-amplified dna', 'intrachromosomal deletion', 'intrachromosomal fold-back inversion', 'intrachromosomal inversion', 'intrachromosomal tandem duplication', 'Intrachromosomal unknown type', 'intrachromosomal with inverted orientation', 'intrachromosomal with non-inverted orientation'. |
Sample | Symbol_a | Chr_a | Start_a | End_a | Symbol_b | Chr_b | Start_b | End_b |
breast | GALNT14 | chr2 | 31207853 | 31207853 | SPATS2L | chr2 | 201339517 | 201339517 |
ovary | GALNT14 | chr2 | 31190663 | 31190683 | ITGB6 | chr2 | 161042792 | 161042812 |
ovary | GALNT14 | chr2 | 31249948 | 31249968 | GALNT14 | chr2 | 31250113 | 31250133 |
pancreas | GALNT14 | chr2 | 31279421 | 31279441 | chr2 | 11991056 | 11991076 | |
pancreas | GALNT14 | chr2 | 31281402 | 31281422 | NRXN1 | chr2 | 50350162 | 50350182 |
pancreas | GALNT14 | chr2 | 31291608 | 31291628 | chr2 | 10424296 | 10424316 | |
pancreas | GALNT14 | chr2 | 31325489 | 31325509 | chr2 | 32576933 | 32576953 | |
pancreas | GALNT14 | chr2 | 31329868 | 31329888 | chr2 | 13678571 | 13678591 | |
pancreas | GALNT14 | chr2 | 31332419 | 31332439 | NRXN1 | chr2 | 50570826 | 50570846 |
cf) Tissue number; Tissue name (1;Breast, 2;Central_nervous_system, 3;Haematopoietic_and_lymphoid_tissue, 4;Large_intestine, 5;Liver, 6;Lung, 7;Ovary, 8;Pancreas, 9;Prostate, 10;Skin, 11;Soft_tissue, 12;Upper_aerodigestive_tract) |
Related fusion transcripts : go to Chitars2.0 |
* From mRNA Sanger sequences, Chitars2.0 arranged chimeric transcripts. This table shows GALNT14 related fusion information. |
ID | Head Gene | Tail Gene | Accession | Gene_a | qStart_a | qEnd_a | Chromosome_a | tStart_a | tEnd_a | Gene_a | qStart_a | qEnd_a | Chromosome_a | tStart_a | tEnd_a |
BU676719 | GALNT14 | 18 | 214 | 2 | 31133333 | 31133529 | GALNT14 | 209 | 417 | 2 | 31133502 | 31133710 | |
CV383660 | KIAA1217 | 2 | 287 | 10 | 24799402 | 24799687 | GALNT14 | 281 | 348 | 2 | 31376003 | 31376070 | |
BU679527 | GALNT14 | 18 | 213 | 2 | 31133333 | 31133529 | GALNT14 | 208 | 416 | 2 | 31133502 | 31133710 | |
BU685357 | GALNT14 | 18 | 214 | 2 | 31133333 | 31133529 | GALNT14 | 209 | 417 | 2 | 31133502 | 31133710 | |
CF143349 | GALNT14 | 7 | 147 | 2 | 31277907 | 31278047 | GALNT14 | 141 | 487 | 2 | 31282580 | 31282926 | |
AK024039 | GALNT14 | 2 | 1620 | 2 | 31147064 | 31361369 | LAMTOR2 | 1619 | 2224 | 1 | 156024587 | 156028296 | |
BQ358366 | KIAA1217 | 1 | 315 | 10 | 24799370 | 24799687 | GALNT14 | 309 | 376 | 2 | 31376003 | 31376070 |
Other DBs for Structural Variants |
Top |
Copy Number Variations in COSMIC: go to COSMIC mutation CNV/Expr |
Mutation type/ Tissue ID | brca | cns | cerv | endome | haematopo | kidn | Lintest | liver | lung | ns | ovary | pancre | prost | skin | stoma | thyro | urina | |||
Total # sample |   |   |   |   |   |   | 1 |   |   |   | 1 |   |   | 1 | 1 |   |   | |||
GAIN (# sample) |   |   |   |   |   |   |   |   |   |   | 1 |   |   | 1 | 1 |   |   | |||
LOSS (# sample) |   |   |   |   |   |   | 1 |   |   |   |   |   |   |   |   |   |   |
cf) Tissue ID; Tissue type (1; Breast, 2; Central_nervous_system, 3; Cervix, 4; Endometrium, 5; Haematopoietic_and_lymphoid_tissue, 6; Kidney, 7; Large_intestine, 8; Liver, 9; Lung, 10; NS, 11; Ovary, 12; Pancreas, 13; Prostate, 14; Skin, 15; Stomach, 16; Thyroid, 17; Urinary_tract) |
Top |
SNV Counts per Each Loci in COSMIC data: go to COSMIC point mutation |
|
Top |
Somatic Mutation Counts per Tissue in COSMIC data |
Stat. for Non-Synonymous SNVs (# total SNVs=66) | (# total SNVs=37) |
(# total SNVs=0) | (# total SNVs=0) |
Top |
Top 10 SNVs Having the Most Samples in COSMIC data |
* When you move the cursor on each content, you can see more deailed mutation information on the Tooltip. Those are primary_site,primary_histology,mutation(aa),pubmedID. |
GRCh37 position | Mutation(aa) | Unique sampleID count |
chr2:31178570-31178570 | p.A190T | 4 |
chr2:31165143-31165143 | p.F285F | 4 |
chr2:31133827-31133827 | p.I533I | 4 |
chr2:31178795-31178795 | p.R172H | 3 |
chr2:31167740-31167740 | p.P271S | 3 |
chr2:31165103-31165103 | p.D299N | 2 |
chr2:31215847-31215847 | p.L52L | 2 |
chr2:31165110-31165110 | p.G296G | 2 |
chr2:31155016-31155016 | p.V326I | 2 |
chr2:31133839-31133839 | p.N529N | 2 |
Top |
SNV Counts per Each Loci in TCGA data |
|
Point Mutation/ Tissue ID | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 |
# sample |   | 1 | 1 | 16 | 3 |   | 5 |   |   |   |   | 17 | 5 | 5 | 1 |   | 28 | 9 | 1 | 9 |
# mutation |   | 1 | 1 | 16 | 3 |   | 5 |   |   |   |   | 18 | 5 | 4 | 1 |   | 35 | 10 | 1 | 11 |
nonsynonymous SNV |   |   | 1 | 13 | 3 |   | 5 |   |   |   |   | 9 | 4 | 2 | 1 |   | 21 | 7 | 1 | 6 |
synonymous SNV |   | 1 |   | 3 |   |   |   |   |   |   |   | 9 | 1 | 2 |   |   | 14 | 3 |   | 5 |
cf) Tissue ID; Tissue type (1; BLCA[Bladder Urothelial Carcinoma], 2; BRCA[Breast invasive carcinoma], 3; CESC[Cervical squamous cell carcinoma and endocervical adenocarcinoma], 4; COAD[Colon adenocarcinoma], 5; GBM[Glioblastoma multiforme], 6; Glioma Low Grade, 7; HNSC[Head and Neck squamous cell carcinoma], 8; KICH[Kidney Chromophobe], 9; KIRC[Kidney renal clear cell carcinoma], 10; KIRP[Kidney renal papillary cell carcinoma], 11; LAML[Acute Myeloid Leukemia], 12; LUAD[Lung adenocarcinoma], 13; LUSC[Lung squamous cell carcinoma], 14; OV[Ovarian serous cystadenocarcinoma ], 15; PAAD[Pancreatic adenocarcinoma], 16; PRAD[Prostate adenocarcinoma], 17; SKCM[Skin Cutaneous Melanoma], 18:STAD[Stomach adenocarcinoma], 19:THCA[Thyroid carcinoma], 20:UCEC[Uterine Corpus Endometrial Carcinoma]) |
Top |
Top 10 SNVs Having the Most Samples in TCGA data |
* We represented just top 10 SNVs. When you move the cursor on each content, you can see more deailed mutation information on the Tooltip. Those are primary_site, primary_histology, mutation(aa), pubmedID. |
Genomic Position | Mutation(aa) | Unique sampleID count |
chr2:31133827 | p.F285L,GALNT14 | 3 |
chr2:31165143 | p.I533I,GALNT14 | 3 |
chr2:31154991 | p.V334G,GALNT14 | 3 |
chr2:31133788 | p.H546H,GALNT14 | 2 |
chr2:31215756 | p.A486T,GALNT14 | 2 |
chr2:31147092 | p.G296G,GALNT14 | 2 |
chr2:31168704 | p.P484S,GALNT14 | 2 |
chr2:31147108 | p.R268C,GALNT14 | 2 |
chr2:31168707 | p.E83K,GALNT14 | 2 |
chr2:31135133 | p.R172H,GALNT14 | 2 |
Other DBs for Point Mutations |
Copy Number for GALNT14 in TCGA |
* Copy number data were extracted from TCGA using R package TCGA-Assembler. The URLs of all public data files on TCGA DCC data server were gathered on Jan-05-2015. Function ProcessCNAData in TCGA-Assembler package was used to obtain gene-level copy number value which is calculated as the average copy number of the genomic region of a gene. |
cf) Tissue ID[Tissue type]: BLCA[Bladder Urothelial Carcinoma], BRCA[Breast invasive carcinoma], CESC[Cervical squamous cell carcinoma and endocervical adenocarcinoma], COAD[Colon adenocarcinoma], GBM[Glioblastoma multiforme], Glioma Low Grade, HNSC[Head and Neck squamous cell carcinoma], KICH[Kidney Chromophobe], KIRC[Kidney renal clear cell carcinoma], KIRP[Kidney renal papillary cell carcinoma], LAML[Acute Myeloid Leukemia], LUAD[Lung adenocarcinoma], LUSC[Lung squamous cell carcinoma], OV[Ovarian serous cystadenocarcinoma ], PAAD[Pancreatic adenocarcinoma], PRAD[Prostate adenocarcinoma], SKCM[Skin Cutaneous Melanoma], STAD[Stomach adenocarcinoma], THCA[Thyroid carcinoma], UCEC[Uterine Corpus Endometrial Carcinoma] |
Top |
Gene Expression for GALNT14 |
Gene Expression in Cancer Cell-lines (CCLE) |
* CCLE gene expression data were extracted from CCLE_Expression_Entrez_2012-10-18.res: Gene-centric RMA-normalized mRNA expression data. |
Differential Gene Expression in Primary Tumors (TCGA) |
* Normalized gene expression data of RNASeqV2 was extracted from TCGA using R package TCGA-Assembler. The URLs of all public data files on TCGA DCC data server were gathered at Jan-05-2015. Only eight cancer types have enough normal control samples for differential expression analysis. (t test, adjusted p<0.05 (using Benjamini-Hochberg FDR)) |
Top |
CNV vs Gene Expression Plot |
* This plots show the correlation between CNV and gene expression. |
Top |
Gene-Gene Network Information |
Co-Expressed gene's network Plot |
* Co-Expression network figures were drawn using R package igraph. Only the top 20 genes with the highest correlations were shown. Red circle: input gene, orange circle: cell metabolism gene, sky circle: other gene |
LINC00488,CDC25A,CENPA,CHEK2,DGKG,EPCAM,FAM136A, FAM64A,FOXM1,GALNT14,GAPDH,GPRIN1,IL13RA2,LRP8, NCAPD2,PSAT1,RANBP1,TRIM51,TEAD4,TPI1,YARS | CADM4,COL8A2,D4S234E,DLK2,FJX1,GALNT14,IL34, IL4R,ITGB4,JAG2,KRT14,KRT5,LAMC2,PDLIM4, PLD4,PPP1R13L,RIPK4,SFN,TACSTD2,TRIM29,WNT10A |
BDNF,ANKUB1,DPY19L2P4,GALNT14,GRM5,GUCA1C,IL1RL1, KHDC1L,KRT1,MBL1P,NRK,NTF4,OR10H4,PCDH9, PLGLA,SACS,SLC35F3,SPANXA2,SPANXB2,SYT16,UTS2B | AADAC,ABCC2,CCL25,CPO,CRISP1,FAM99A,FAM99B, FMO1,GALNT14,GRAMD1B,GSTA5,LCE3E,LOC388428,MME, MOS,ONECUT3,OR10H1,OR10H5,OR4N5,PWAR4___F2RL3___PAWR,SHBG, SLC28A1,SLC2A2,SOAT2,SPA |
Co-Expressed gene's Protein-protein interaction Network Plot |
* Co-Expression network figures were drawn using R package igraph. Only the top 20 genes with the highest correlations were shown. Red circle: input gene, orange circle: cell metabolism gene, sky circle: other gene |
Top |
Interacting Genes (from Pathway Commons) |
Top |
Pharmacological Information for GALNT14 |
There's no related Drug. |
Top |
Cross referenced IDs for GALNT14 |
* We obtained these cross-references from Uniprot database. It covers 150 different DBs, 18 categories. http://www.uniprot.org/help/cross_references_section |
Copyright © 2016-Present - The Univsersity of Texas Health Science Center at Houston @ |